Statins and brain dysfunction in intensive care

The Lancet Respiratory Medicine

Volumn 4, Issue 3, 2016, Pages 169-170

  Sharshar, Tarek ^a,b   Polito, Andrea ^a   Bozza, Fernando ^c   Chrétien, Fabrice ^b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; ROSUVASTATIN;

AMYGDALOID NUCLEUS; APOPTOSIS; ASTROCYTE; AUTOREGULATION; BLOOD BRAIN BARRIER; BRAIN DYSFUNCTION; COGNITIVE DEFECT; CRITICAL ILLNESS; DELIRIUM; DISSEMINATED INTRAVASCULAR CLOTTING; EXECUTIVE FUNCTION; FRONTAL CORTEX; HUMAN; INTENSIVE CARE; ISCHEMIA; MENTAL DISEASE; MORTALITY; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NEUROTRANSMISSION; NOTE; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SEPSIS; UNSPECIFIED SIDE EFFECT; BRAIN; INTENSIVE CARE UNIT;

BRAIN; CRITICAL CARE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTENSIVE CARE UNITS;

EID: 84959542740     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)00028-X     Document Type: Note

References (13)

1. Polito A, Eischwald F, Maho AL, et al. Pattern of brain injury in the acute setting of human septic shock. Crit Care 2013, 17:R204.
2. Azabou E, Magalhaes E, Braconnier A, et al. Early standard electroencephalogram abnormalities predict mortality in septic intensive care unit patients. PLoS One 2015, 10:e0139969.
3. Annane D, Sharshar T Cognitive decline after sepsis. Lancet Respir Med 2015, 3:61-69.
4. Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med 2013, 369:1306-1316.
5. Sharshar T, Gray F, Lorin de la Grandmaison G, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003, 362:1799-1805.
6. d'Avila JC, Santiago AP, Amancio RT, Galina A, Oliveira MF, Bozza FA Sepsis induces brain mitochondrial dysfunction. Crit Care Med 2008, 36:1925-1932.
7. Heneka MT, Widmann CN Long-term cerebral consequences of sepsis. Lancet Neurol 2014, 13:630-636.
8. Sharshar T, Porcher R, Siami S, et al. Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med 2011, 39:1960-1967.
9. Needham DM, Colantuoni E, Dinglas VD, et al. Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial. Lancet Respir Med 2016, published online Jan 28. http://dx.doi.org/10.1016/S2213-2600(16)00005-9.
10. Page VJ, Davis D, Zhao XB, et al. Statin use and risk of delirium in critically ill patients. Am J Resp Crit Care 2014, 189:666-673.
11. Morandi A, Hughes CG, Thompson JL, et al. Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med 2014, 42:1899-1909.
12. Reis PA, Estato V, da Silva TI, et al. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog 2012, 8:e100309.
13. Thomas G, Hraiech S, Loundou A, et al. Statin therapy in critically-ill patients with severe sepsis: a review and meta-analysis of randomized clinical trials. Minerva Anestesiol 2015, 8:921-930.